RIV Capital Inc.
CNPOFOTCHealthcare
$0.08
+$0.00(+0.00%)
Market Cap$10957519
P/E Ratio—
52W High$0.169
52W Low$0.0621
RIV Capital Inc. (CNPOF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CNPOF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2023Report Date: Jun 15, 2023EPS Actual
-$0.04
Revenue
$0.00B
Est. $0.00B · +217.8%
Fiscal Period
Q2 FY2023
FY ends December
Report Date
Jun 15, 2023
After Market Close
▲ Beat Revenue
CNPOF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2025 | Apr 28, 2025 | — | — | — | — | — | — |
| ◌ Q4 FY2024 | Nov 27, 2024 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Aug 28, 2024 | — | — | — | — | — | — |
| ◌ Q2 FY2024 | May 30, 2024 | — | — | — | — | — | — |
| ◌ Q1 FY2024 | Feb 28, 2024 | — | — | — | — | — | — |
| ◌ Q4 FY2023 | Nov 29, 2023 | — | — | — | — | — | — |
| ◌ Q3 FY2023 | Aug 28, 2023 | — | — | — | — | — | — |
| — Q2 FY2023 | Jun 15, 2023 | — | -$0.04 | — | $0.00B | $0.00B | +217.8% |
Q2 FY2025
Apr 28, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 27, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 28, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
May 30, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Feb 28, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 29, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 28, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2023
Jun 15, 2023
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2023 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2023 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2023 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2023 | Jun 15, 2023 | — | $0.09 | $0.10 | +8.81% |
| — Q1 FY2023 | Mar 1, 2023 | — | $0.12 | $0.12 | +3.10% |
| — Q4 FY2022 | Nov 29, 2022 | — | $0.22 | $0.27 | +25.16% |
| — Q3 FY2022 | Aug 28, 2022 | — | $0.43 | $0.42 | -2.60% |
| — Q2 FY2022 | Jun 13, 2022 | — | $0.55 | $0.52 | -5.21% |
Q2 FY2023+8.81%
Report Date
Jun 15, 2023
EPS Beat/Miss
—
Price Before
$0.09
Price After
$0.10
Q1 FY2023+3.10%
Report Date
Mar 1, 2023
EPS Beat/Miss
—
Price Before
$0.12
Price After
$0.12
Q4 FY2022+25.16%
Report Date
Nov 29, 2022
EPS Beat/Miss
—
Price Before
$0.22
Price After
$0.27
Q3 FY2022-2.60%
Report Date
Aug 28, 2022
EPS Beat/Miss
—
Price Before
$0.43
Price After
$0.42
Q2 FY2022-5.21%
Report Date
Jun 13, 2022
EPS Beat/Miss
—
Price Before
$0.55
Price After
$0.52
Beat Rate0 / 5 quarters
Largest Move+25.16% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CNPOF ends December
RIV Capital Inc. (CNPOF) most recently reported earnings on June 15, 2023 for Q2 FY2023, posting EPS of $-0.04 (in line with the analyst consensus of —). The next CNPOF earnings date is expected around September 1, 2026.
Each quarter, investors track CNPOF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CNPOF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CNPOF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CNPOF earnings · 4 questionsRIV Capital Inc.'s next earnings report is expected around September 1, 2026. CNPOF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CNPOF historically reports after market close (AMC).
CNPOF earnings datewhen is CNPOF earningsCNPOF next earnings datewhen does CNPOF report earningsCNPOF earnings calendar
▸ Source: FMP · RIV Capital Inc. SEC filings · US GAAP · RIV Capital Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026